|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 2006;81:304
© 2006 The Society of Thoracic Surgeons
Division of Thoracic Surgical Oncology, Fox Chase Cancer Center, 333 Cottman Ave C312, Philadelphia, PA 19111
(Email: m_goldberg@fccc.edu).
| The first 20% of the full text of this article appears below. |
Enatsu and colleagues [1] have defined the importance of positive pleural lavage cytology both before and after resection in all stages of surgically resectable nonsmall cell lung cancer. The data clearly supports that those patients with positive cytology (particularly in post-resection specimens) do poorly, with none surviving greater than 4 years.
Recently several groups have identified a survival advantage of as great as 15%, using adjuvant chemotherapy in resected early stage nonsmall cell lung cancer. Possibly many of these patients may
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |